Skip to main content

LIVE

AIXC

AIxCrypto Holdings, Inc.

AIXC

NASDAQ·Technology·Software - Infrastructure·Mkt cap $14.4M

$0.71

+1.91%

P/E

Mkt Cap

$14.4M

52-Wk Range

$0.59–$8.81

52-Week Range

$0.59 - $8.81

P/E

Fwd P/E

Beta

0.53

Div Yield

0.00%

Avg Vol

906.2K

Shares Out

5.2M

Mkt Cap

$14.4M

Price action

Price chart

Down 59.0% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Novel G-quadruplexes-selective transcription inhibitor mechanism
  • Clinical-stage pipeline with multiple oncology programs
  • Established regulatory pathway and clinical trial expertise
  • Intellectual property portfolio in targeted cancer therapeutics

Bear Case

1 risk

  • Low volatility (beta 0.5).

Growth

No forward estimates available

Advancement of QN-302 through Phase I clinical trials

Value

Valuation data unavailable

Momentum

Falling

-45.0% over 3m

Quality

Loss-making

Below average quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 17, 2026

Q3 26 RECAP

AUG 7, 2026

Reported EPS of -$0.21 vs -$70.00 consensus (+99.7% surprise).

EPS beat +99.7%

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+99.7%

Revenue trend · last 8Q

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$0

$0

$0

$0

$0

$0

$0

$0

Margins · last 8Q

No margin history available.

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

vs Industry

How AIXC stacks vs Software - Infrastructure

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.